The results of GSVA showed that MTFP1 upregulated IL-17 signaling pathways, calcium signaling pathways, breast cancer, negative regulation of epithelial cell apoptotic process, negative regulation of endothelial cell apoptotic process, fibrinolysis and signaling pathways regulating pluripotency of stem cells (Figure 6C); MTFP1 showed negative correlation to most immune cells (Figure 6J), indicating that MTFP1 promotes tumor growth and progression. Here, IL17A is linked to breast carcinoma.